Respiratory Syncytial Virus Bronchiolitis Clinical Trial
Official title:
Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.
NCT number | NCT02618213 |
Other study ID # | S-20150007 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 1, 2015 |
Est. completion date | May 1, 2018 |
Verified date | October 2022 |
Source | Hospital of South West Jutland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Bronchiolitis in infants and young children often requires respiraty support. In Denmark Continous Positive Airway Pressure ( CPAP) are routinely used in children with moderate-severe bronchiolitis. The aim of the study is to compare CPAP and High Flow Oxygenation Therapy (HFOT) as tools of respiratory support in infants and young children with bronchiolitis. Infants and young children with moderate-severe bronchiolitis and are randomized to either CPAP or HFOT.
Status | Completed |
Enrollment | 50 |
Est. completion date | May 1, 2018 |
Est. primary completion date | May 1, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Day to 24 Months |
Eligibility | Inclusion Criteria: - infants and children with moderate respiratoric syncytial virus bronchiolitis or other viral bronchiolitis and need of respiratory support. ( clinical decision) Exclusion Criteria: - severe bronchiolitis with P C02 > 9, decreased consciusness and risk for early progression to intensive therapy. |
Country | Name | City | State |
---|---|---|---|
Denmark | Hospital Lillebaelt | Kolding | |
Denmark | Signe Vahlkvist | Kolding |
Lead Sponsor | Collaborator |
---|---|
Hospital of South West Jutland |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | respiration rate | change in respiration rate ( RR) from preintervention value | after 6 12 18 24 and 48 hour of intervention | |
Primary | PCo2 | Change in PCo2 (partial pressure of carbon dioxide)from pre intervention value | after 6 12 24 and 48 hours of intervention | |
Primary | Modified asthma score (MWAS) | Change in MWAS from pre intervention value | Once daily as long as intervention precedes ( 1-14 days) | |
Secondary | treatment length | duration of need of intervention ( hours) | from beginning of intervention to discontinuation (1-14 days) | |
Secondary | Hspitalization | duration of hospitalisation ( days) | from hospitalization to release (1-21 days) | |
Secondary | Intervention failure. | numbers of intervention failure defined as change of intervention or progression to need for intensive care/ mechanical ventilation. | from beginning of intervention to discontinuation.(1-14 days) | |
Secondary | patient acceptance of intervention | VAS score of tolerance with intervention. 0 = worst possible acceptance 5 = fully acceptance | daily VAS score (0-5) from beginning of intervention to discontinuation (1-14 days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01140048 -
Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)
|